RSV Monoclonal Antibodies Highly Effective in Infants
Global analysis of more than 60,000 RSV viral sequences reveals that resistance to monoclonal antibodies remains rare.
Global analysis of more than 60,000 RSV viral sequences reveals that resistance to monoclonal antibodies remains rare.
Less than 44% of people in the US received a flu shot during the 2025-2026 season, down from 52% in 2021.
People with a COVID-19 history showed a significantly stronger breathing response following brief arousals from sleep.
CVS and Walgreens are expanding walk-in access, multi-vaccine scheduling, and respiratory illness testing ahead of peak viral activity.
Merck is seeking expand approval for its RSV drug Enflonsia to include children under age two through their second year of risk.
The discovery of sorting nexin 5 provides insight into how the body signals infection and manages tissue damage.